Peripheral neuropathy Board decisions

The Veteran's diabetes mellitus type II was granted a 40% disability rating effective October 14, 2021. The initial ratings for RLE and LLE diabetic peripheral neuropathy were denied.

The Board denied service connection for peripheral neuropathy of the left and right lower extremities, finding that there was no evidence to support a direct relationship with service or herbicide exposure.

The Board has remanded the Veteran's claims for higher ratings due to inadequate reasons and bases provided in previous decisions. The Veteran needs a new examination to determine the current severity of his service-connected right lower extremity neurological disabilities.

The Board has granted service connection for coronary artery disease due to exposure to herbicide agents under the PACT Act.,The Veteran's claim for diabetes is denied as there is no current diagnosis of diabetes.

The Veteran's service-connected diabetic peripheral neuropathy of the right and left lower extremities is being remanded for a new examination to assess its current severity.

The Veteran's claim for diabetes mellitus type II and peripheral neuropathy of the upper and lower extremities is denied as there is no current disability.,The Veteran's claim for peripheral neuropathy of the left upper extremity, right upper extremity, left lower extremity, and right lower extremity on a secondary basis and as due to herbicide agent exposure is denied.,The Veteran's claim for skin disorder (claimed as chloracne, manifested by rashes) on a secondary basis and as due to herbicide agent exposure is denied.

The Board denied service connection for diabetes mellitus, dysentery, and malaria. Service connection was granted for jungle rot, right lower extremity neuropathy, and left lower extremity neuropathy.,Service connection for duodenal ulcers, skin cancer, and a prostate disability is remanded.

The Veteran's diabetes mellitus is granted as presumed due to herbicide exposure.,His peripheral neuropathy, bilateral lower extremities and upper extremities are secondary to his service-connected diabetes mellitus.,His diabetic retinopathy is also secondary to his service-connected diabetes mellitus.,His erectile dysfunction is also secondary to his service-connected diabetes mellitus.,The Veteran's bilateral cataracts are not currently diagnosed, but if diagnosed, would be considered secondary to his service-connected diabetes mellitus.

The Board has granted service connection for diabetes mellitus type II on a presumptive basis due to herbicide agent exposure in Thailand. The issues of service connection for peripheral neuropathy, left and right lower extremities are remanded.

The Veteran's service-connected peripheral neuropathy of the left and right lower extremities resulted in mild incomplete paralysis of the sciatic nerve, which does not warrant a rating higher than 10 percent.

The Board has determined that the claims for service connection for residuals of rectal cancer, lung cancer, right upper extremity peripheral neuropathy, left upper extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and left lower extremity peripheral neuropathy must be remanded due to inadequate development regarding potential chemical exposure in service.

The Board has granted service connection for multiple conditions, including cell lymphocyte deficiency, hypogammaglobulinemia, premature ovarian failure, asymmetrical sensorineural hearing loss, peripheral neuropathy, thyroid dysfunction, diabetes mellitus, fibromyalgia, chronic laryngitis, muscle weakness, hypertension, cholecystitis, and basal cell carcinoma, all of which are related to the Veteran's in-service exposure to ethylene oxide, formaldehyde, methanol, and phenol.

The Board has granted service connection for chronic lymphocytic leukemia, type 2 diabetes, hypertension, and polyneuropathy of the bilateral lower extremities (secondary to service-connected type 2 diabetes). Service connection for memory loss and syncope is denied.

The Board denied service connection for the claimed conditions as due to herbicide exposure, finding that there was no evidence of such exposure during active duty.

The Board has remanded the claims for service connection for peripheral neuropathy of the left lower extremity, right upper extremity, and left upper extremity due to herbicide exposure and/or secondary to diabetes. Additional VA examinations are needed to address the Veteran's testimony regarding ongoing symptoms and the nature and etiology of his peripheral neuropathy.

The Board has granted service connection for bilateral upper and lower extremity peripheral neuropathy, finding that it is secondary to the Veteran's service-connected essential tremors.

The Board denied the Veteran's claim for service connection for lumbar radiculopathy of the bilateral lower extremities, finding that his current condition is related to non-service-connected degenerative disc disease/degenerative arthritis of the lumbosacral spine and diabetic neuropathy.

The Board has denied the Veteran's claims for service connection for peripheral neuropathy of both his right and left lower extremities, finding that there is no evidence linking these conditions to his active duty service.

The Board has denied service connection for glaucoma, a heart disorder (claimed as heart attack with stents and congestive heart failure), hypertension, neuropathy, and a tumor in the knee. The evidence does not establish that these conditions began during or within one year of active service, are related to an in-service injury or disease, or are secondary to the Veteran's service-connected degenerative disc disease of the lumbar spine.

The Veteran's claims for higher ratings for his right and left lower extremity sciatic nerve neuropathy associated with diabetes mellitus have been denied by the Board.